<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DIMENHYDRINATE- dimenhydrinateÂ injection, solutionÂ </strong><br>APP Pharmaceuticals, LLC<br></p></div>
<h1>Dimenhydrinate Injection USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ae41059c-08c2-48e8-a088-e06d16c4b046"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First">Rx only<br></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="aada81cb-4bb1-4ec1-b341-1a06898d248e"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Dimenhydrinate, an anti-nauseant/antiemetic, is the 8-chlorotheophylline salt of diphenhydramine.Â  It contains not less than 53% and not more than 55.5% of diphenhydramine, and not less than 44% and not more than 47% of 8-chlorotheophylline, calculated on the dried basis.Â  Chemically, it is 8-chlorotheophylline compound with 2(diphenylmethoxy)-N,N-dimethylethylamine (1:1), and the structural formula is:</p>
<p><img alt="Dimenhydrinatestructure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bc71539e-1a33-4709-8a24-c2894e8dbc1c&amp;name=dimenhydrinate-injection-usp-figure-1-Dimenhydrinate_structure_.jpg"></p>
<br><p>Â <span class="Bold"><span class="Emphasis">C</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">17</span></span></span><span class="Bold"><span class="Emphasis">H</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">21</span></span></span><span class="Bold"><span class="Emphasis">NOâ€¢C</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">7</span></span></span><span class="Bold"><span class="Emphasis">H</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">7</span></span></span><span class="Bold"><span class="Emphasis">ClN</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">4</span></span></span><span class="Bold"><span class="Emphasis">O</span></span><span class="Bold"><span class="Emphasis"><span class="Sub">2</span></span></span><span class="Bold"><span class="Emphasis"> Â Â Â Â Â Â Â Â Â Â Â  Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  </span></span><span class="Bold"><span class="Emphasis">M.W. 469.96</span></span></p>
<p>Dimenhydrinate Injection, USP contains a sterile solution of Dimenhydrinate 50 mg/mL; Propylene Glycol 50%; Benzyl Alcohol 5% as preservative; and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid may have been used to adjust pH.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="f14af44f-ce0a-45da-a405-bf9f59f8760b"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">While the precise mode of action of dimenhydrinate is not known, it has a depressant action on hyperstimulated labyrinthine function.<br></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="a9890ff3-fdfd-47d1-97e6-b14003807daa"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Dimenhydrinate Injection, USP is indicated for the prevention and treatment of <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, or <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span> of <span class="product-label-link" type="condition" conceptid="30284" conceptname="Motion sickness">motion sickness</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="a4fe4462-03d3-4cce-8bd7-02b1ebb29560"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Neonates and patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to dimenhydrinate or its components (diphenhydramine or 8-chlorotheophylline) should not be treated with dimenhydrinate.</p>
<p><span class="Bold"><span class="Emphasis">Note: </span></span>This product contains Benzyl Alcohol.Â  Benzyl Alcohol has been associated with a fatal â€œGasping Syndromeâ€? in premature infants and infants of low birth weight.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="e4be7fb5-abb9-48d3-a8b2-3ce360167b68"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Caution should be used when dimenhydrinate is given in conjunction with certain antibiotics that may cause <span class="product-label-link" type="condition" conceptid="4236623" conceptname="Ototoxicity">ototoxicity</span>, since dimenhydrinate is capable of masking ototoxic symptoms, and an irreversible state may be reached. </p>
<p>This drug may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks, such as driving a vehicle or operating machinery. Â The concomitant use of alcohol or other central nervous system depressants may have an additive effect. Therefore, patients should be warned accordingly.</p>
<p>Dimenhydrinate should be used with caution in patients having conditions which might be aggravated by anticholinergic therapy (i.e., <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span>, stenosing <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, pyloroduodenal obstruction, <span class="product-label-link" type="condition" conceptid="433813" conceptname="Bladder neck obstruction">bladder neck obstruction</span>, narrow-angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, or <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>).</p>
<p>The preparation should not be injected intra-arterially.</p>
<div class="Section" data-sectionCode="34071-1">
<a name="f2283a4b-90be-44b4-8662-593d4414c016"></a><a name="section-6.1"></a><p></p>
<h2>Pediatric Patients<br>
</h2>
<p class="First">For infants and children especially, antihistamines in overdosage may cause <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p>As in adults, antihistamines may diminish mental alertness in pediatric patients. Â In the young child, particularly, they may produce excitation (see <span class="Bold"><span class="Emphasis"><a href="#a4fe4462-03d3-4cce-8bd7-02b1ebb29560">CONTRAINDICATIONS</a></span></span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="c5972a1c-d3bb-4456-9a9a-8a47f6d885cf"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="42232-9">
<a name="d9172c4a-c1c2-4a31-99cb-5b7fa1483adb"></a><a name="section-7.1"></a><p></p>
<h2>General<br>
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Drowsiness</span> may be experienced by some patients, especially with high dosage. Â This effect frequently is not undesirable in conditions for which the drug is used.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ac5f2d08-44c1-4a46-8ec7-b1539498f638"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients<br>
</h2>
<p class="First">Because of the potential for <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, patients taking dimenhydrinate should be cautioned against operating automobiles or dangerous machinery (see <span class="Bold"><span class="Emphasis"><a href="#e4be7fb5-abb9-48d3-a8b2-3ce360167b68">WARNINGS</a></span></span>).</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="b1a7ca2d-caa3-45ef-b30a-9db601e1d9b1"></a><a name="section-7.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility<br>
</h2>
<p class="First">Mutagenicity screening tests performed with dimenhydrinate, diphenhydramine, and 8-chlorotheophylline produced positive results in the bacterial systems and negative results in the mammalian systems. Â There are no human data that indicate dimenhydrinate is a carcinogen or mutagen or that it impairs fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="a16a6e37-6ad5-45d0-97a1-4f39d309c709"></a><a name="section-7.4"></a><p></p>
<h2>Pregnancy<br>
</h2>
<p class="First"><span class="Italics"><span class="Emphasis">Pregnancy Category B.</span></span></p>
<p>Reproduction studies have been performed in rats at doses up to 20 times the human dose, and in rabbits at doses up to 25 times the human dose (on a mg/kg basis), and have revealed no evidence of impaired fertility or harm to the fetus due to dimenhydrinate. There are no adequate and well-controlled studies in pregnant women.Â  However, clinical studies in pregnant women have not indicated that dimenhydrinate increases the risk of abnormalities when administered in any trimester of pregnancy. Â It would appear that the possibility of fetal harm is remote when the drug is used during pregnancy. Â Nevertheless, because the studies in humans cannot rule out the possibility of harm, dimenhydrinate should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="adfd1a4e-5990-4305-8e7a-38084833d940"></a><a name="section-7.5"></a><p></p>
<h2>Labor and Delivery<br>
</h2>
<p class="First">The safety of dimenhydrinate given during labor and delivery has not been established. Reports have indicated dimenhydrinate may have an oxytocic effect. Â Caution is advised when this effect is unwanted or in situations where it may prove detrimental.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="af624492-8d00-41cf-8aa8-9e4a954464bd"></a><a name="section-7.6"></a><p></p>
<h2>Nursing Mothers<br>
</h2>
<p class="First">Small amounts of dimenhydrinate are excreted in breast milk. Â Because of the potential for adverse reactions in nursing infants from dimenhydrinate, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="c20d68af-f4fa-449c-b9dd-374b7cc0a0be"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The most frequent adverse reaction to dimenhydrinate is <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>. Â <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span> may also occur.Â  Symptoms of <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, nose and throat, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, difficult or <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">painful urination</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorexia</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span> or <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span> (especially in pediatric patients), <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, thickening of bronchial secretions, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">lassitude</span>, excitation, and <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> have been reported.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="d0e841cb-ebf7-4d01-bbaf-f57038e66c98"></a><a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Drowsiness</span> is the usual clinical side effect. Â <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Convulsions</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, and <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> may occur with massive overdosage. Â No specific antidote is known. Â If <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span> occurs, mechanically assisted respiration should be initiated and oxygen should be administered.Â  <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">Convulsions</span> should be treated with appropriate doses of diazepam.Â  Phenobarbital (5 to 6 mg/kg) may be given to control <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> in pediatric patients. </p>
<p>The oral LD<span class="Sub">50</span> in mice and rats is 203 mg/kg and 1320 mg/kg, respectively. Â The intraperitoneal LD<span class="Sub">50</span> in mice is 149 mg/kg.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="f3dd2a2a-4256-4cef-804b-ef5d0b655a10"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Dimenhydrinate in the injectable form is indicated when the oral form is impractical.</p>
<div class="Section" data-sectionCode="34068-7">
<a name="ddec9dcb-2989-47fb-ac95-90ae6af0c1b0"></a><a name="section-10.1"></a><p></p>
<h2>Adults<br>
</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span> or <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> may be expected to be controlled for approximately 4 hours with 50 mg, and prevented by a similar dose every 4 hours. Â Its administration may be attended by some degree of <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> in some patients, and 100 mg every 4 hours may be given in conditions in which <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> is not objectionable or is even desirable.</p>
<p>For intramuscular administration, each milliliter (50 mg) of solution is injected as needed, but for intravenous administration, each milliliter (50 mg) of solution must be diluted in 10 mL of 0.9% Sodium Chloride Injection, USP and injected over a period of 2 minutes.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="b6737d01-ce80-4d88-90e5-66b16d9b2b7f"></a><a name="section-10.2"></a><p></p>
<h2>Pediatric<br>
</h2>
<p class="First">For intramuscular administration, 1.25 mg/kg of body weight or 37.5 mg/m<span class="Sup">2</span> of body surface area is administered four times daily. Â The maximum dose should not exceed 300 mg daily (see <span class="Bold"><span class="Emphasis"><a href="#a4fe4462-03d3-4cce-8bd7-02b1ebb29560">CONTRAINDICATIONS</a></span></span>).</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="b49b4ed5-3afa-475a-8b4c-39e9e00b7e0b"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">DimenhyDRINATE Injection, USP, 50 mg/mL is available in multiple dose amber vials, as follows:</p>
<table>
<colgroup>
<col align="left">
<col align="left">
<col align="left">
<col align="left">
</colgroup>
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">Product </span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top">
<p class="First"><span class="Bold"><span class="Emphasis">NDC</span></span></p>
<p><span class="Bold"><span class="Emphasis">No.</span></span></p>
</td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First"><span class="Bold"><span class="Emphasis">Strength</span></span></p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First"><span class="Bold"><span class="Emphasis">Vial Size</span></span></p></td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">361601</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">63323-366-01</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">50 mg/mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">1 mL in 2 mL vial, in packages of 25.</p></td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">361610</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">63323-366-10</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">50 mg/mL</p></td>
<td class="Botrule Lrule Rrule Toprule" align="left" valign="top"><p class="First">10 mL in a 10 mL vial, packaged individually.</p></td>
</tr>
</tbody>
</table>
<p>Protect from light.</p>
<p>Store at 20Â° to 25Â°C (68Â° to 77Â°F)[see USP Controlled Room Temperature].</p>
<p>Vial stoppers do not contain natural rubber latex.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="bdc1a20e-e48a-4c6d-880d-aecca7c2df9d"></a><a name="section-12"></a><p></p>
<h1></h1>
<p class="First"><img alt="logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bc71539e-1a33-4709-8a24-c2894e8dbc1c&amp;name=dimenhydrinate-injection-usp-figure-2-add_band_logo.jpg"></p>
<p>45981B</p>
<p>Revised: April 2008</p>
<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="f5bc544f-a1ee-456c-8fc2-09d449c8d7e4"></a><a name="section-13"></a><p></p>
<h1></h1>
<span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY - Dimenhydrinate 1 mL Vial Label
Â 
Â 
Â 
Â 
</span></span><p class="First"><span class="Bold"><span class="Emphasis">NDC</span></span> 63323-366-01</p>
<p>361601</p>
<p><span class="Bold"><span class="Emphasis">DIMENHYDRINATE INJECTION, USP</span></span></p>
<p><span class="Bold"><span class="Emphasis">50 mg/mL</span></span></p>
<p>For IM Use</p>
<p>For IV Use: See package insert.</p>
<p>Rx only</p>
<p><span class="Bold"><span class="Emphasis">1 mL</span></span> Multiple Dose Vial</p>
<p>Â </p>
<p>Â <img alt="361601vial" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bc71539e-1a33-4709-8a24-c2894e8dbc1c&amp;name=dimenhydrinate-injection-usp-figure-3-361601vial.jpg"></p>
<p><span class="Bold"><span class="Emphasis">PACKAGE LABEL - PRINCIPAL DISPLAY - Dimenhydrinate 1 mL Tray Label </span></span></p>
<p><span class="Bold"><span class="Emphasis">NDC </span></span>63323-366-01</p>
<p>361601</p>
<p><span class="Bold"><span class="Emphasis">DIMENHYDRINATE INJECTION, USP</span></span></p>
<p><span class="Bold"><span class="Emphasis">50 mg/mL</span></span></p>
<p>For IM Use</p>
<p>*For IV Use</p>
<p>Rx only</p>
<p><span class="Bold"><span class="Emphasis">1 mL</span></span> Multiple Dose Vial</p>
<p>Â </p>
<p><img alt="361601-tray" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=bc71539e-1a33-4709-8a24-c2894e8dbc1c&amp;name=dimenhydrinate-injection-usp-figure-4-361601-tray.jpg"><br>
Â </p>
<span class="Bold"><span class="Emphasis"><br></span></span>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DIMENHYDRINATEÂ 		
					</strong><br><span class="contentTableReg">dimenhydrinate injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:63323-366</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR, INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DIMENHYDRINATE</strong> (DIMENHYDRINATE) </td>
<td class="formItem">DIMENHYDRINATE</td>
<td class="formItem">50Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZYL ALCOHOL</strong></td>
<td class="formItem">0.05Â mL Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem">0.5Â mL Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:63323-366-01</td>
<td class="formItem">25  in 1 TRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1 mL in 1 VIAL</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040519</td>
<td class="formItem">11/29/2004</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>APP Pharmaceuticals, LLC
							(608775388)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">APP Pharmaceuticals, LLC</td>
<td class="formItem"></td>
<td class="formItem">840771732</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 8/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9de9d0c5-be81-4bc3-b1db-77b248d3ec7c</div>
<div>Set id: bc71539e-1a33-4709-8a24-c2894e8dbc1c</div>
<div>Version: 1</div>
<div>Effective Time: 20110823</div>
</div>
</div>Â <div class="DistributorName">APP Pharmaceuticals, LLC</div></p>
</body></html>
